Lymphoproliferative Disorders after Immunosuppressive Therapy for Aplastic Anemia: A Case Report and Literature Review

Publisher： Karger

E-ISSN： 1421-9662|121|1|21-26

ISSN： 0001-5792

Source： Acta Haematologica, Vol.121, Iss.1, 2009-03, pp. : 21-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive Factors for Cure after Immunosuppressive Therapy of Aplastic Anemia

By  

Acta Haematologica, Vol. 103, Iss. 1, 2000-03 ,pp. : 55-62

Karger

Access to resources Recommend Favorite

Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia

By  

Acta Haematologica, Vol. 136, Iss. 3, 2016-08 ,pp. : 174-177

Karger

Access to resources Recommend Favorite

Epstein‐Barr virus‐induced polyclonal lymphoproliferative disorder of lymphoplasmacytic type in an autopsy case of aplastic anemia treated twice with anti‐thymocyte globulin therapy

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 5, 2015-05 ,pp. : 274-276

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subcutaneous Nocardial Abscesses in a Patient with Bullous Pemphigoid during Immunosuppressive Therapy: Report of a Case and Review of the Japanese Literature

By  

THE JOURNAL OF DERMATOLOGY, Vol. 26, Iss. 12, 1999-12 ,pp. : 829-833

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 259-264

John Wiley & Sons Inc

Access to resources Recommend Favorite